These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 34059198

  • 1. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
    Di Buduo CA, Laurent PA, Zaninetti C, Lordier L, Soprano PM, Ntai A, Barozzi S, La Spada A, Biunno I, Raslova H, Bussel JB, Kaplan DL, Balduini CL, Pecci A, Balduini A.
    Elife; 2021 Jun 01; 10():. PubMed ID: 34059198
    [Abstract] [Full Text] [Related]

  • 2. Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation.
    Di Buduo CA, Currao M, Pecci A, Kaplan DL, Balduini CL, Balduini A.
    Haematologica; 2016 Dec 01; 101(12):1479-1488. PubMed ID: 27515246
    [Abstract] [Full Text] [Related]

  • 3. Eltrombopag in chronic hepatitis C.
    Mihăilă RG, Cipăian RC.
    World J Gastroenterol; 2014 Sep 21; 20(35):12517-21. PubMed ID: 25253952
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombopoietin receptor agonists in hereditary thrombocytopenias.
    Rodeghiero F, Pecci A, Balduini CL.
    J Thromb Haemost; 2018 Sep 21; 16(9):1700-1710. PubMed ID: 29956472
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.
    Erhardt JA, Erickson-Miller CL, Aivado M, Abboud M, Pillarisetti K, Toomey JR.
    Exp Hematol; 2009 Sep 21; 37(9):1030-7. PubMed ID: 19631713
    [Abstract] [Full Text] [Related]

  • 9. Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.
    Sun H, Tsai Y, Nowak I, Liesveld J, Chen Y.
    Stem Cell Res; 2012 Sep 21; 9(2):77-86. PubMed ID: 22683680
    [Abstract] [Full Text] [Related]

  • 10. Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome.
    Will B, Kawahara M, Luciano JP, Bruns I, Parekh S, Erickson-Miller CL, Aivado MA, Verma A, Steidl U.
    Blood; 2009 Oct 29; 114(18):3899-908. PubMed ID: 19710504
    [Abstract] [Full Text] [Related]

  • 11. Eltrombopag to allow chemotherapy in a patient with MYH9-related inherited thrombocytopenia and pancreatic cancer.
    Paciullo F, Bury L, Gresele P.
    Int J Hematol; 2020 Nov 29; 112(5):725-727. PubMed ID: 32557126
    [Abstract] [Full Text] [Related]

  • 12. Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
    Erickson-Miller CL, Delorme E, Tian SS, Hopson CB, Landis AJ, Valoret EI, Sellers TS, Rosen J, Miller SG, Luengo JI, Duffy KJ, Jenkins JM.
    Stem Cells; 2009 Feb 29; 27(2):424-30. PubMed ID: 19038790
    [Abstract] [Full Text] [Related]

  • 13. A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
    Svensson T, Chowdhury O, Garelius H, Lorenz F, Saft L, Jacobsen SE, Hellström-Lindberg E, Cherif H.
    Eur J Haematol; 2014 Nov 29; 93(5):439-45. PubMed ID: 24853277
    [Abstract] [Full Text] [Related]

  • 14. Thrombopoietin receptor agonists in primary immune thrombocytopenia.
    Siegal D, Crowther M, Cuker A.
    Semin Hematol; 2013 Jan 29; 50 Suppl 1(0 1):S18-21. PubMed ID: 23664510
    [Abstract] [Full Text] [Related]

  • 15. The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma.
    Jeong JY, Levine MS, Abayasekara N, Berliner N, Laubach J, Vanasse GJ.
    J Hematol Oncol; 2015 Apr 16; 8():37. PubMed ID: 25886818
    [Abstract] [Full Text] [Related]

  • 16. Platelet enhancement by Carica papaya L. leaf fractions in cyclophosphamide induced thrombocytopenic rats is due to elevated expression of CD110 receptor on megakaryocytes.
    Nandini C, Madhunapantula SV, Bovilla VR, Ali M, Mruthunjaya K, Santhepete MN, Jayashree K.
    J Ethnopharmacol; 2021 Jul 15; 275():114074. PubMed ID: 33831466
    [Abstract] [Full Text] [Related]

  • 17. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.
    Tanaka T, Inamoto Y, Yamashita T, Fuji S, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Fukuda T.
    Biol Blood Marrow Transplant; 2016 May 15; 22(5):919-24. PubMed ID: 26785333
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.
    Pecci A.
    Int J Hematol; 2013 Jul 15; 98(1):34-47. PubMed ID: 23636669
    [Abstract] [Full Text] [Related]

  • 19. Eltrombopag: a review of its use in treatment-refractory chronic primary immune thrombocytopenia.
    Garnock-Jones KP.
    Drugs; 2011 Jul 09; 71(10):1333-53. PubMed ID: 21770480
    [Abstract] [Full Text] [Related]

  • 20. Protein and Small-Molecule Leucopoiesis and Thrombopoiesis Stimulators.
    Farsa O, Zubáč P.
    Mini Rev Med Chem; 2021 Jul 09; 21(13):1638-1645. PubMed ID: 33390132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.